Business Wire

Green Hydrogen Close to a Breakthrough

Share

The climate protection goals as well as the massive increase in the price of fossil fuels and the need for energy security are giving the energy transition a tailwind. Green hydrogen is a key element on the way to decarbonizing industry, transport and energy supply and is close to a market breakthrough. The task is to establish complete value chains. At the second “Green Hydrogen Forum” as part ofEurope’s largest platform of the energy industry The smarter E Europe, everything will revolve around green hydrogen from May 11 to 13, 2022 at Messe München. Exhibition tickets can now be booked.

“The green hydrogen economy is an essential part of the solution for Europe to ensure the means to supply itself much more independently and fossil-free in the future, especially during crises and wars,” says Dr. Michael Spirig, CEO of the European Electrolyser & Fuel Cell Forum (EFCF). “It is now important to invest in all components of the value chain at the same time, so that green production, storage and consumption can grow continuously together,” explains Spirig.

Green Hydrogen Forum & Expo” provides impetus for the industry

The “Green Hydrogen Forum & Expo” will be held as part of ees Europe 2022 in Hall B2: over three days, international experts will speak at the forum on political framework conditions, the international markets, the required infrastructure, and lighthouse projects. In the kick-off session on May 11, Jorgo Chatzimarkakis, CEO of the European trade association Hydrogen Europe, will speak on the role of hydrogen as an accelerator of resilience in the European energy system. Prof. Dr. Veronika Grimm, member of the Council of Economic Experts of the German Federal Government, will conclude with a presentation on hydrogen and its economic efficiency as well as its economic importance for Germany and Europe.

In a panel-discussion focusing on the necessary measures for the industrial use of hydrogen, Mr. Chatzimarkakis will engage with other industry insiders such as Werner Diwald (Managing Director of the German Hydrogen and Fuel Cell Association DWV) and Cornelius Matthes, CEO of Dii Desert Energy.

In the associated exhibition area, companies will be presenting products and services related to hydrogen, fuel cells, electrolysis and power-to-gas.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Solar Promotion GmbH
Horst Dufner | Tel.: +49 7231 58598-0
dufner@solarpromotion.de

Press contact:
fischerAppelt, relations
Felizia Rein| Tel. +49 89 74 74 66 40
felizia.rein@fischerappelt.de

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Align Announces Additional Leadership for UK and EMEA to Support Continued Growth18.5.2022 17:11:00 CEST | Press release

Align, the premier global provider of technology infrastructure solutions celebrates significant growth throughout the UK and EMEA markets with management changes to support increasing demand. The appointment of Giulia Marcolina as Managing Director and Mike Konold as AV Solutions Director of Align’s UK-based headquarters, will enable the team to deliver innovative collaborative technology and state-of-the-art AV solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220518005833/en/ Giulia Marcolina, a 15 year veteran with Align, is named Managing Director of Align's UK-based headquarters. (Photo: Business Wire) Giulia brings over 25 years of IT experience, previously serving as Align’s Programme Manager, delivering corporate office relocation and consolidation projects for clients such as Blackrock, Total Gas and Power, and UBS. In her new role, she will lead Align’s team of project managers in building upon Align’s lon

RMS Advances Climate Risk Modeling and Moves More Models to High Definition18.5.2022 16:30:00 CEST | Press release

RMS®, a Moody’s Analytics company and world-leading risk modeling and solutions company, today announces it will be releasing four new High Definition™ (HD) models, including Europe Windstorm, North America Winterstorm (WT), North America Severe Convective Storm (SCS), and Terrorism. RMS HD Models represent the next generation of risk modeling, delivering deeper analysis and granularity from Moody’s. The HD probabilistic models incorporate a high-fidelity, simulation-based framework for modeling event frequency and severity, to provide a major step forward in the quality of catastrophe risk quantification. The framework allows for event footprints to be represented more realistically across larger event sets. The new RMS Europe Windstorm HD Model further enhances the current model and will cover 17 countries, adding Finland and Lichtenstein. The HD model includes a climate variability view and has expanded storm surge analytics to include the U.K., Ireland, France, and Belgium. Storm c

Suketu Upadhyay Elected to Vertex Board of Directors18.5.2022 16:30:00 CEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Suketu (“Suky”) Upadhyayhas been elected to its board of directors as an independent director. Mr. Upadhyay is a global business executive with more than 20 years of experience in the pharmaceutical and medical technology sectors, serving in financial and strategy roles covering multiple areas of the life sciences sector. He is currently the Executive Vice President and Chief Financial Officer of Zimmer Biomet, a leading global innovator and manufacturer of orthopedic solutions, a position he has held since July 2019. “We are delighted to have Suky join the Vertex Board. His extensive financial and strategic experience in health care, paired with his leadership and expertise across biopharma and medtech, make him a valuable addition to our board of directors,” said Reshma Kewalramani, M.D., Vertex’s Chief Executive Officer and President. “It’s an honor to join Vertex, a company focused on serial innovation with an

Armory Makes Continuous Deployment Achievable and Effortless, at any Scale, for all Developers18.5.2022 16:17:00 CEST | Press release

Armory, the Continuous Deployment company empowering development teams to easily, reliably, safely, and continuously deploy software at any scale, today announced public early access to their new Continuous Deployment-as-a-Service product. Armory Continuous Deployment-as-a-Service delivers declarative deployments, across multiple environments, that support advanced strategies, so developers can focus on building great code rather than deploying it. “We believe deploying software continuously, at any scale, should be achievable and effortless for all developers of the world, not just the likes of Google and Netflix,” said Jim Douglas, President and CEO, Armory. “It’s our vision and mission to unlock innovation through software to make software continuous, scalable, secure, and safe, so developers can improve and protect their customers’ experience with confidence and ease.” To effectively compete in a software-defined world, development teams must ensure a stellar customer experience. S

Sermo Survey Reveals New Lung & Breast Cancer Research Rated as Most Interesting by Oncologists Attending ASCO This Year18.5.2022 15:15:00 CEST | Press release

A new survey from Sermo, a physician-first online community and leader in global HCP insights, timed to the annual American Society of Clinical Oncology (ASCO) conference found that nearly half (47%) of attending oncologists are most interested in new data being presented about lung cancer. This is followed by a similarly high interest in new data about breast cancer, as reported by 44% of oncologists surveyed. Additionally, oncologists/hematologists reported they are most excited about learning about tumor targeting antibodies treatments as reported by 54% of those surveyed. Ahead of ASCO’s Annual Meeting, new cancer research and innovations are the driving reason surveyed oncologists/hematologists are attending the conference this year (59%). However, how they plan to attend looks different to many oncologists, as only 18% of oncologists/hematologists surveyed said they will attend ASCO in-person this year. A Look Into the Pandemic’s Negative Impacts on Cancer Care Globally Oncologis

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom